Revvity, Inc.

Revvity, Inc. is a life sciences and diagnostics company headquartered in Waltham, Massachusetts. Until 2023 it carried the name PerkinElmer, and its roots go back to Perkin-Elmer, founded in 1937. The new name was adopted after the sale of its applied, food and enterprise services business. Its shares trade on the New York Stock Exchange under the ticker RVTY, and it is a member of the S&P 500 index.

Activities run in two main divisions. The life sciences division offers reagents used in drug discovery and biological research, imaging instruments, cell and gene therapy tools and laboratory information management software. The diagnostics division serves areas such as newborn screening, immunity and allergy testing, reproductive health and infectious disease testing. Customers include pharmaceutical and biotechnology companies, academic research institutions and clinical laboratories. Part of the company's diagnostic testing products is sold to organizations that run the tests in their own laboratories.

Those following Revvity stock typically track research spending in the pharmaceutical sector, academic research budgets, diagnostic test volumes and demand conditions in large markets such as China. On the RVTY page at Lzzo.com the price is shown in US dollars, and a historical price chart and technical indicators appear on the same page.